Long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants.

The melanocortin 4 receptor (MC4R) critically regulates feeding and satiety. Rare variants in MC4R are predominantly found in obese individuals. Though some rare variants in MC4R discovered in patients have defects in localization, ligand binding and signaling to cAMP, many have no recognized defect...

Full description

Bibliographic Details
Main Authors: Bryn S Moore, Uyenlinh L Mirshahi, Evan A Yost, Ann N Stepanchick, Michael D Bedrin, Amanda M Styer, Kathryn K Jackson, Christopher D Still, Gerda E Breitwieser, Glenn S Gerhard, David J Carey, Tooraj Mirshahi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3976318?pdf=render
id doaj-ba09539673d243149dc56a008e394908
record_format Article
spelling doaj-ba09539673d243149dc56a008e3949082020-11-25T01:56:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0194e9362910.1371/journal.pone.0093629Long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants.Bryn S MooreUyenlinh L MirshahiEvan A YostAnn N StepanchickMichael D BedrinAmanda M StyerKathryn K JacksonChristopher D StillGerda E BreitwieserGlenn S GerhardDavid J CareyTooraj MirshahiThe melanocortin 4 receptor (MC4R) critically regulates feeding and satiety. Rare variants in MC4R are predominantly found in obese individuals. Though some rare variants in MC4R discovered in patients have defects in localization, ligand binding and signaling to cAMP, many have no recognized defects.In our cohort of 1433 obese subjects that underwent Roux-en-Y Gastric Bypass (RYGB) surgery, we found fifteen variants of MC4R. We matched rare variant carriers to patients with the MC4R reference alleles for gender, age, starting BMI and T2D to determine the variant effect on weight-loss post-RYGB. In vitro, we determined expression of mutant receptors by ELISA and western blot, and cAMP production by microscopy.While carrying a rare MC4R allele is associated with obesity, carriers of rare variants exhibited comparable weight-loss after RYGB to non-carriers. However, subjects carrying three of these variants, V95I, I137T or L250Q, lost less weight after surgery. In vitro, the R305Q mutation caused a defect in cell surface expression while only the I137T and C326R mutations showed impaired cAMP signaling. Despite these apparent differences, there was no correlation between in vitro signaling and pre- or post-surgery clinical phenotype.These data suggest that subtle differences in receptor signaling conferred by rare MC4R variants combined with additional factors predispose carriers to obesity. In the absence of complete MC4R deficiency, these differences can be overcome by the powerful weight-reducing effects of bariatric surgery. In a complex disorder such as obesity, genetic variants that cause subtle defects that have cumulative effects can be overcome after appropriate clinical intervention.http://europepmc.org/articles/PMC3976318?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Bryn S Moore
Uyenlinh L Mirshahi
Evan A Yost
Ann N Stepanchick
Michael D Bedrin
Amanda M Styer
Kathryn K Jackson
Christopher D Still
Gerda E Breitwieser
Glenn S Gerhard
David J Carey
Tooraj Mirshahi
spellingShingle Bryn S Moore
Uyenlinh L Mirshahi
Evan A Yost
Ann N Stepanchick
Michael D Bedrin
Amanda M Styer
Kathryn K Jackson
Christopher D Still
Gerda E Breitwieser
Glenn S Gerhard
David J Carey
Tooraj Mirshahi
Long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants.
PLoS ONE
author_facet Bryn S Moore
Uyenlinh L Mirshahi
Evan A Yost
Ann N Stepanchick
Michael D Bedrin
Amanda M Styer
Kathryn K Jackson
Christopher D Still
Gerda E Breitwieser
Glenn S Gerhard
David J Carey
Tooraj Mirshahi
author_sort Bryn S Moore
title Long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants.
title_short Long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants.
title_full Long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants.
title_fullStr Long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants.
title_full_unstemmed Long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants.
title_sort long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description The melanocortin 4 receptor (MC4R) critically regulates feeding and satiety. Rare variants in MC4R are predominantly found in obese individuals. Though some rare variants in MC4R discovered in patients have defects in localization, ligand binding and signaling to cAMP, many have no recognized defects.In our cohort of 1433 obese subjects that underwent Roux-en-Y Gastric Bypass (RYGB) surgery, we found fifteen variants of MC4R. We matched rare variant carriers to patients with the MC4R reference alleles for gender, age, starting BMI and T2D to determine the variant effect on weight-loss post-RYGB. In vitro, we determined expression of mutant receptors by ELISA and western blot, and cAMP production by microscopy.While carrying a rare MC4R allele is associated with obesity, carriers of rare variants exhibited comparable weight-loss after RYGB to non-carriers. However, subjects carrying three of these variants, V95I, I137T or L250Q, lost less weight after surgery. In vitro, the R305Q mutation caused a defect in cell surface expression while only the I137T and C326R mutations showed impaired cAMP signaling. Despite these apparent differences, there was no correlation between in vitro signaling and pre- or post-surgery clinical phenotype.These data suggest that subtle differences in receptor signaling conferred by rare MC4R variants combined with additional factors predispose carriers to obesity. In the absence of complete MC4R deficiency, these differences can be overcome by the powerful weight-reducing effects of bariatric surgery. In a complex disorder such as obesity, genetic variants that cause subtle defects that have cumulative effects can be overcome after appropriate clinical intervention.
url http://europepmc.org/articles/PMC3976318?pdf=render
work_keys_str_mv AT brynsmoore longtermweightlossingastricbypasspatientscarryingmelanocortin4receptorvariants
AT uyenlinhlmirshahi longtermweightlossingastricbypasspatientscarryingmelanocortin4receptorvariants
AT evanayost longtermweightlossingastricbypasspatientscarryingmelanocortin4receptorvariants
AT annnstepanchick longtermweightlossingastricbypasspatientscarryingmelanocortin4receptorvariants
AT michaeldbedrin longtermweightlossingastricbypasspatientscarryingmelanocortin4receptorvariants
AT amandamstyer longtermweightlossingastricbypasspatientscarryingmelanocortin4receptorvariants
AT kathrynkjackson longtermweightlossingastricbypasspatientscarryingmelanocortin4receptorvariants
AT christopherdstill longtermweightlossingastricbypasspatientscarryingmelanocortin4receptorvariants
AT gerdaebreitwieser longtermweightlossingastricbypasspatientscarryingmelanocortin4receptorvariants
AT glennsgerhard longtermweightlossingastricbypasspatientscarryingmelanocortin4receptorvariants
AT davidjcarey longtermweightlossingastricbypasspatientscarryingmelanocortin4receptorvariants
AT toorajmirshahi longtermweightlossingastricbypasspatientscarryingmelanocortin4receptorvariants
_version_ 1724981624871845888